Abdel-Malek RR - Search Results

1

Rationale for co-targeting CDK4/6 and FGFR pathways in urothelial carcinoma.

Shohdy KS, Vlachostergios PJ, Abdel-Malek RR, Faltas BM. Shohdy KS, et al. Among authors: abdel malek rr. Expert Opin Ther Targets. 2019 Feb;23(2):83-86. doi: 10.1080/14728222.2019.1559828. Epub 2018 Dec 17. Expert Opin Ther Targets. 2019. PMID: 30558440 No abstract available.

2

Safety issues with the ALK inhibitors in the treatment of NSCLC: A systematic review.

Kassem L, Shohdy KS, Lasheen S, Abdel-Rahman O, Ali A, Abdel-Malek RR. Kassem L, et al. Among authors: abdel malek rr. Crit Rev Oncol Hematol. 2019 Feb;134:56-64. doi: 10.1016/j.critrevonc.2018.11.004. Epub 2018 Dec 1. Crit Rev Oncol Hematol. 2019. PMID: 30771874

3

Safety of Vinflunine in Patients with Advanced Urothelial Carcinoma Refractory to Platinum-based Chemotherapy: A Prospective Pilot Study.

Abdel-Malek R, Shohdy KS, Abbas N, Ismail M, Hamada E, Abdel-Kader Y. Abdel-Malek R, et al. Curr Drug Saf. 2019;14(1):31-36. doi: 10.2174/1574886313666181001120752. Curr Drug Saf. 2019. PMID: 30277164

4

The Emerging Treatment Options of Plasmablastic Lymphoma: Analysis of 173 Individual Patient Outcomes.

Makady NF, Ramzy D, Ghaly R, Abdel-Malek RR, Shohdy KS. Makady NF, et al. Among authors: abdel malek rr. Clin Lymphoma Myeloma Leuk. 2021 Mar;21(3):e255-e263. doi: 10.1016/j.clml.2020.11.025. Epub 2020 Dec 3. Clin Lymphoma Myeloma Leuk. 2021. PMID: 33419717 Review.

5

Addition of 3-day aprepitant to ondansetron and dexamethasone for prophylaxis of chemotherapy-induced nausea and vomiting among patients with diffuse large B cell lymphoma receiving 5-day cisplatin-based chemotherapy.

Abdel-Malek R, Abbas N, Shohdy KS, Ismail M, Fawzy R, Salem DS, Safwat E. Abdel-Malek R, et al. J Egypt Natl Canc Inst. 2017 Sep;29(3):155-158. doi: 10.1016/j.jnci.2017.05.001. Epub 2017 Aug 24. J Egypt Natl Canc Inst. 2017. PMID: 28844591 Free article. Clinical Trial.

6

Availability of Informal Caregivers for Palliative Care Patients with Cancer: Is there a Difference between Higher- and Lower-Income Settings.

Abdel-Malek R, Farag DE, Shohdy KS, Cox S. Abdel-Malek R, et al. Indian J Palliat Care. 2019 Jul-Sep;25(3):379-382. doi: 10.4103/IJPC.IJPC_199_18. Indian J Palliat Care. 2019. PMID: 31413452 Free PMC article.

7

Efficacy and toxicity of sunitinib in metastatic renal cell carcinoma patients in Egypt.

Edesa WA, Abdelmalek RR. Edesa WA, et al. Asian Pac J Cancer Prev. 2015;16(5):1971-6. doi: 10.7314/apjcp.2015.16.5.1971. Asian Pac J Cancer Prev. 2015. PMID: 25773796 Free article.

8

Predicting Brain Metastasis in Breast Cancer Patients: Stage Versus Biology.

Azim HA, Abdel-Malek R, Kassem L. Azim HA, et al. Clin Breast Cancer. 2018 Apr;18(2):e187-e195. doi: 10.1016/j.clbc.2017.08.004. Epub 2017 Aug 18. Clin Breast Cancer. 2018. PMID: 28888580

9

Evaluation of target volume margins for radiotherapy of prostate implanted with fiducial markers.

Fawzy R, Abdel-Malek R, Metwaly M, Abdelaziz O, Seleem A. Fawzy R, et al. Radiol Phys Technol. 2020 Jun;13(2):152-159. doi: 10.1007/s12194-020-00563-6. Epub 2020 Mar 19. Radiol Phys Technol. 2020. PMID: 32193798

10

Impact of imatinib interruption and duration of prior hydroxyurea on the treatment outcome in patients with chronic myeloid leukemia: Single institution experience.

Edesa WA, Abdel-malek RR. Edesa WA, et al. Among authors: abdel malek rr. J Egypt Natl Canc Inst. 2015 Jun;27(2):69-75. doi: 10.1016/j.jnci.2015.03.004. Epub 2015 Apr 13. J Egypt Natl Canc Inst. 2015. PMID: 25882857 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

17 results

Search Page